Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AVGR

Avinger Inc

Dec 07 • 02:56PM ET

3.08

Dollar change -0.08
Percentage change -2.53	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-33.00	Insider Own	5.10%	Shs Outstand	1.28M	Perf Week	6.39%
Market Cap	3.94M	Forward P/E	-	EPS next Y	-2.26	Insider Trans	0.00%	Shs Float	1.21M	Perf Month	-13.96%
Income	-18.61M	PEG	-	EPS next Q	0.64	Inst Own	4.52%	Short Float / Ratio	0.37% / 0.00	Perf Quarter	-52.01%
Sales	7.75M	P/S	0.51	EPS this Y	94.51%	Inst Trans	-	Short Interest	0.00M	Perf Half Y	-63.97%
Book/sh	-1.06	P/B	-	EPS next Y	37.05%	ROA	-76.33%	Target Price	5.00	Perf Year	-82.89%
Cash/sh	6.81	P/C	0.45	EPS next 5Y	-	ROE	-973.16%	52W Range	2.78 - 24.30	Perf YTD	-81.07%
Dividend	-	P/FCF	-	EPS past 5Y	80.37%	ROI	-	52W High	-87.32%	Beta	1.36
Dividend %	-	Quick Ratio	0.55	Sales past 5Y	-2.34%	Gross Margin	29.84%	52W Low	10.79%	ATR	0.32
Employees	71	Current Ratio	0.85	Sales Q/Q	-19.32%	Oper. Margin	-204.49%	RSI (14)	41.27	Volatility	10.56% 6.68%
Optionable	No	Debt/Eq	-	EPS Q/Q	74.60%	Profit Margin	-240.18%	Rel Volume	0.01	Prev Close	3.16
Shortable	Yes	LT Debt/Eq	-	Earnings	Oct 26 AMC	Payout	-	Avg Volume	1.94M	Price	3.08
Recom	1.00	SMA20	-3.70%	SMA50	-24.11%	SMA200	-64.35%	Volume	20,859	Change	-2.53%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-29-21	Initiated	B. Riley Securities	Buy	$2.50
Mar-09-18	Initiated	Ladenburg Thalmann	Buy
Apr-12-17	Downgrade	Oppenheimer	Outperform → Perform
Apr-11-17	Downgrade	Canaccord Genuity	Buy → Hold	$4.30 → $1
Dec-29-15	Downgrade	Dougherty & Company	Buy → Neutral
May-08-15	Reiterated	Dougherty & Company	Buy	$16 → $18
Apr-29-15	Initiated	Dougherty & Company	Buy	$16
Feb-24-15	Initiated	Oppenheimer	Outperform	$15
Feb-24-15	Initiated	Canaccord Genuity	Buy	$18

Oct-27-23 08:24AM	Avinger, Inc. (NASDAQ:AVGR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 06:40PM	Avinger (AVGR) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
05:33PM	Avinger: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Avinger Reports Third Quarter 2023 Results (ACCESSWIRE)
Oct-19-23 08:00AM	Avinger to Announce Third Quarter 2023 Results on October 26 (ACCESSWIRE)
08:00AM	Loading…
Sep-27-23 08:00AM	Avinger Raises $5.3 Million via At-The-Market Facility (ACCESSWIRE) -13.67%
Sep-18-23 08:00AM	Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device (ACCESSWIRE) +46.80%
Aug-25-23 12:38PM	Unmasking the Value Trap: A Deep Dive into Avinger Inc (AVGR) (GuruFocus.com) -11.55%
Aug-24-23 08:00AM	Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023 (ACCESSWIRE)
Aug-04-23 09:00AM	Avinger Announces Conversion of 12% of CRG Term Debt into Equity (ACCESSWIRE)
Jul-28-23 06:15AM	Q2 2023 Avinger Inc Earnings Call (Thomson Reuters StreetEvents) -16.87%
Jul-27-23 06:35PM	Avinger (AVGR) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +8.97%
05:33PM	Avinger: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Avinger Reports Second Quarter 2023 Results (ACCESSWIRE)
Jul-20-23 08:00AM	Avinger to Announce Second Quarter 2023 Results on July 27 (ACCESSWIRE) +16.67%
08:00AM	Loading…
Jun-20-23 08:00AM	Avinger Announces Presentations by Key Opinion Leaders at LINC 2023 (ACCESSWIRE) +5.39%
Jun-09-23 08:00AM	Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference (ACCESSWIRE)
Jun-07-23 08:00AM	Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System (ACCESSWIRE)
Jun-05-23 08:00AM	Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device (ACCESSWIRE) +7.66%
May-11-23 05:28AM	Q1 2023 Avinger Inc Earnings Call (Thomson Reuters StreetEvents) -5.77%
May-10-23 04:36PM	Avinger: Q1 Earnings Snapshot (AP Finance) +7.42%
04:01PM	Avinger Reports First Quarter 2023 Results (ACCESSWIRE)
May-02-23 08:00AM	Avinger to Announce First Quarter 2023 Results on May 10 (ACCESSWIRE)
Apr-28-23 08:00AM	Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium (ACCESSWIRE) -11.22%
Apr-26-23 08:00AM	Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System (ACCESSWIRE) +13.51%
Mar-16-23 07:35AM	Q4 2022 Avinger Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-15-23 04:20PM	Avinger: Q4 Earnings Snapshot (AP Finance)
04:01PM	Avinger Reports Fourth Quarter 2022 Results (ACCESSWIRE)
Mar-02-23 08:00AM	Avinger to Announce Fourth Quarter 2022 Results on March 15 (ACCESSWIRE)
Jan-11-23 08:15AM	Avinger Announces 510(k) Filing of Pantheris LV (ACCESSWIRE) +7.09%
08:02AM	Loading…
Nov-12-22 08:02AM	Avinger Third Quarter 2022 Earnings: US$0.77 loss per share (vs US$1.25 loss in 3Q 2021) (Simply Wall St.)
Nov-09-22 04:01PM	Avinger Reports Third Quarter 2022 Results (ACCESSWIRE)
Nov-04-22 08:00AM	Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices (ACCESSWIRE)
Nov-01-22 07:45AM	Avinger to Announce Third Quarter 2022 Results on November 9 (ACCESSWIRE)
Oct-19-22 08:00AM	Avinger to Present at LD Micro Investor Conference (ACCESSWIRE)
Sep-07-22 08:30AM	BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council (GlobeNewswire)
Sep-01-22 08:00AM	Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022 (ACCESSWIRE)
Aug-11-22 04:30PM	Edited Transcript of AVGR.OQ earnings conference call or presentation 11-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents)
04:05PM	Avinger Reports Second Quarter 2022 Results (ACCESSWIRE)
Aug-08-22 03:15PM	Avinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE) +5.59%
Aug-05-22 08:00AM	Avinger to Announce Second Quarter 2022 Results on August 11 (ACCESSWIRE)
Aug-04-22 08:00AM	Avinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE)
Jul-06-22 08:00AM	Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System (ACCESSWIRE)
Jun-21-22 07:30AM	Avinger Expands International Presence with First Commercial Shipment to Chile (ACCESSWIRE)
Jun-15-22 08:30AM	Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022 (ACCESSWIRE) +6.85%
Jun-06-22 08:30AM	Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference (ACCESSWIRE)
May-16-22 08:00AM	Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany (ACCESSWIRE)
May-10-22 05:55PM	Avinger (AVGR) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:02PM	Avinger Reports First Quarter 2022 Results (ACCESSWIRE)
May-04-22 07:45PM	AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-29-22 09:00AM	Avinger to Announce First Quarter 2022 Results on May 10 (ACCESSWIRE)
Apr-19-22 08:00AM	Avinger Announces Full Commercial Launch of Lightbox 3 (ACCESSWIRE)
Mar-30-22 08:00AM	Avinger Announces Issuance of Three New U.S. Patents in March 2022 (ACCESSWIRE) +10.29%
Mar-29-22 04:05PM	Avinger Regains Compliance with Nasdaq Listing Requirements (ACCESSWIRE) +6.71%
Mar-22-22 05:15PM	Avinger (AVGR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Avinger Reports Fourth Quarter and Year End 2021 Results (ACCESSWIRE)
Mar-15-22 07:30AM	Avinger to Announce Full-Year 2021 Results on March 22 (ACCESSWIRE) -15.83%
Mar-14-22 08:00AM	Avinger to Effect One-for-Twenty Reverse Stock Split (ACCESSWIRE) -26.29%
Mar-08-22 08:55AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +7.66%
Mar-07-22 07:30AM	Avinger Expands Lightbox 3 First Case Experience (ACCESSWIRE) -7.74%
Mar-02-22 07:58AM	Health Check: How Prudently Does Avinger (NASDAQ:AVGR) Use Debt? (Simply Wall St.) -6.18%
Feb-28-22 08:15AM	Avinger Announces Successful Completion of First Cases with the Lightbox 3 Next Generation Imaging Console (ACCESSWIRE) +13.04%
Feb-24-22 05:30PM	Natus Medical (NTUS) Beats Q4 Earnings and Revenue Estimates (Zacks)
Feb-22-22 05:55PM	Tactile Systems Technology (TCMD) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.90%
Jan-14-22 04:01PM	Avinger Announces Closing of $7.6 Million Registered Direct Offering (ACCESSWIRE)
Jan-12-22 08:00AM	Avinger Announces $7.6 Million Registered Direct Offering (ACCESSWIRE) -25.67%
Jan-11-22 08:30AM	Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console (ACCESSWIRE)
Nov-17-21 12:45PM	Todays Hot Penny Stocks: Whats Moving ZSAN, AVGR and CEI Higher Wednesday? (InvestorPlace) +6.57%
08:30AM	Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis (ACCESSWIRE)
Nov-11-21 04:01PM	Avinger Reports Third Quarter 2021 Financial Results (ACCESSWIRE)
Nov-04-21 03:01PM	Avinger (AVGR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
06:00AM	Vinco Ventures Stock Is Looking for Fools to Believe. Dont Be One of Them (InvestorPlace)
Oct-29-21 08:30AM	Avinger to Announce Third Quarter Results on November 11, 2021 (ACCESSWIRE)
Oct-07-21 11:00AM	Avinger's Shares Move Higher As Pantheris Shows Safety, Efficacy For In-Stent Restenosis (Benzinga) +12.62%
08:45AM	Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA (ACCESSWIRE)
Sep-08-21 08:45AM	Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15 (ACCESSWIRE)
Sep-03-21 07:38AM	Does Avinger (NASDAQ:AVGR) Have A Healthy Balance Sheet? (Simply Wall St.)
Aug-16-21 08:00AM	Avinger OCT-Guided Technologies Featured at AMP 2021 (ACCESSWIRE)
Aug-10-21 04:01PM	Avinger Reports Second Quarter 2021 Financial Results (ACCESSWIRE)
Aug-09-21 07:30AM	Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console (ACCESSWIRE) +7.45%
Jul-27-21 04:00PM	Avinger to Announce Second Quarter 2021 Results on August 10, 2021 (ACCESSWIRE)
Jul-22-21 09:20AM	10 Best One Dollar Stocks to Buy Now (Insider Monkey)
Jul-06-21 08:30AM	Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication (ACCESSWIRE)
Jun-28-21 08:45AM	Avinger Announces Key Opinion Leader Presentations at Vascular Conferences in Germany (ACCESSWIRE)
Jun-13-21 02:37PM	Here is What Hedge Funds Think About Avinger Inc (AVGR) (Insider Monkey)
Jun-07-21 08:00AM	Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference (ACCESSWIRE) +11.76%
May-25-21 08:30AM	Avinger Announces Issuance and Allowance of Seven U.S. Patents (ACCESSWIRE)
May-17-21 08:00AM	Avinger To Present at the Oppenheimer MedTech, Tools & Diagnostics Summit May 26 (ACCESSWIRE)
May-09-21 03:35AM	Announcing: Avinger (NASDAQ:AVGR) Stock Increased An Energizing 228% In The Last Year (Simply Wall St.)
May-06-21 04:01PM	Avinger Reports First Quarter 2021 Financial Results (ACCESSWIRE)
02:45PM	Avinger, Inc. to Host Earnings Call (ACCESSWIRE)
Apr-26-21 08:30AM	Avinger to Announce First Quarter 2021 Results on May 6, 2021 (ACCESSWIRE) +5.98%
Apr-21-21 08:00AM	New Publications Highlight Clinical Benefits of Avinger PAD Therapies (ACCESSWIRE) +25.77%
Apr-15-21 08:00AM	Avinger Achieves Commercial Milestone with More Than 100 Accounts Using Pantheris SV (ACCESSWIRE) -5.47%
Apr-08-21 08:30AM	Avinger Provides Update on Tigereye(TM) Commercial Launch (ACCESSWIRE)
Mar-11-21 04:50PM	Avinger: Q4 Earnings Insights (Benzinga) +9.32%
04:01PM	Avinger Reports Fourth Quarter 2020 Financial Results (ACCESSWIRE)
02:30PM	Avinger, Inc. to Host Earnings Call (ACCESSWIRE)
08:35AM	Avinger, Inc. to Present at the Q1 Virtual Investor Summit (GlobeNewswire)
Mar-10-21 10:08AM	Earnings Outlook For Avinger (Benzinga)

Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Subainati Nabeel Paul	Vice President, Finance	Mar 23	Sale	0.81	223	181	85,672	Mar 24 04:36 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AVGR

Avinger Inc

Upgrade your FINVIZ experience